Standard of care for urethritis

N 1675n On approval of the standard for primary health care for non-specific and other urethritis

N 1675n On approval of the standard of primary health care for non-specific and other urethritis

See help about standards of care

In accordance with Article 37 of the Federal Law of November 21, 2011 6724; 2012, N 26, Art. 3442, 3446) order:

Approve the standard for primary health care for non-specific and other urethritis according to the annex.

Registration N 27528

A standard of medical care has been approved that defines the basic requirements for the diagnosis and treatment of patients with nonspecific and other urethritis. The standard is recommended for use in the provision of primary health care.

N 1675n On approval of the standard of primary health care for non-specific and other urethritis

Registration N 27528

This order comes into force 10 days after the date of its official publication

N 136/1 (special edition)

Standard for Primary Health Care for Non-Specific and Other Urethritis

Standard for Primary Health Care for Non-Specific and Other Urethritis

STANDARD

PRIMARY HEALTH CARE FOR NON-SPECIFIC HEALTH CARE

AND ANOTHER URETHRI

Age category: adults

Complications: no complications

Type of care: primary health care

Conditions of medical care: outpatient

Form of medical care: planned

Average treatment time (number of days): 14

N34.1 Nonspecific urethritis

N34.2 Other urethritis

1. Medical measures for diagnosing a disease, condition

Reception (examination, consultation) of a specialist doctor

Medical service code

Name of medical service

Average rate of submission

Average indicator of the multiplicity of applications

Primary appointment (examination, consultation) with a urologist

The probability of providing medical services or prescribing drugs for medical use (medical devices) included in the standard of care, which can take values from 0 to 1, where 1 means that this event is carried out by 100% of patients corresponding to this model, and the numbers are less than 1 percentage of patients specified in the standard of care with relevant medical indications.

Laboratory research methods

Medical service code

Name of medical service

Average rate of submission

Average indicator of the multiplicity of applications

Microscopic examination of prostate secretion sediment

Molecular biological blood test for ureaplasma (Ureaplasma urealiticum)

Microbiological examination of the discharge of female genital organs for ureaplasma (Ureaplasma urealyticum)

Microscopic examination of discharge from the urethra for gonococcus (Neisseria gonorrhoeae)

Microbiological examination of discharge from the urethra for mycoplasmas (Mycoplasma genitalium) and ureaplasma (Ureaplasma urealyticum)

Microscopic examination of discharge from the urethra for gardnerella (Gardnerella vaginalis)

Bacteriological examination of the secretion of the prostate for aerobic and facultative anaerobic conditionally pathogenic microorganisms

Molecular biological study of discharge from the urethra on chlamydia (Chlamidia trachomatis)

Parasitological examination of prostate secretion for Trichomonas trophozoites (Trichomonas vaginalis)

General urinalysis

2.Medical services for the treatment of a disease, condition and treatment control

Reception (examination, consultation) and supervision of a medical specialist

Medical service code

Name of medical service

Average rate of submission

Average indicator of the multiplicity of applications

Repeated appointment (examination, consultation) with a urologist

Laboratory research methods

Medical service code

Name of medical service

Average rate of submission

Average indicator of the multiplicity of applications

Microscopic examination of prostate secretion sediment

Molecular biological blood test for ureaplasma (Ureaplasma urealiticum)

Microbiological examination of the discharge of female genital organs for ureaplasma (Ureaplasma urealyticum)

Microscopic examination of discharge from the urethra for gonococcus (Neisseria gonorrhoeae)

Microbiological examination of discharge from the urethra for mycoplasmas (Mycoplasma genitalium) and ureaplasma (Ureaplasma urealyticum)

Microscopic examination of discharge from the urethra for gardnerella (Gardnerella vaginalis)

Bacteriological examination of the secretion of the prostate for aerobic and facultative anaerobic conditionally pathogenic microorganisms

Molecular biological study of discharge from the urethra on chlamydia (Chlamidia trachomatis)

Parasitological examination of prostate secretion for Trichomonas trophozoites (Trichomonas vaginalis)

General urinalysis

3

Anatomical-therapeutic-chemical classification

Medication name

Average rate of submission

International Statistical Classification of Diseases and Related Health Problems, X revision.

International generic or chemical name of the medicinal product, and in their absence, the trade name of the medicinal product.

Average daily dose.

Average course dose.

1

2. 6724; 06/25/2012, N 26, art. 3442)).

3. 3699; 2004, N 35, Art. 3607; 2006, N 48, Art. 4945; 2007, N 43, Art. 5084; 2008, N 9, Art. 817; 2008, N 29, Art. 3410; No. 52, art. 6224; 2009, N 18, art. 2152; No. 30, art. 3739; No. 52, art. 6417; 2010, No. 50, Art. 6603; 2011, N 27, art. 3880; 2012, N 31, st

On the approval of the standard for primary health care for nonspecific and other urethritis

Document as of August 2014

N 27528

In accordance with Article 37 of the Federal Law of November 21, 2011 6724; 2012, N 26, Art. 3442, 3446) order:

Approve the standard for primary health care for non-specific and other urethritis according to the annex.

N 1675n

Age category: adults

Complications: no complications

Type of care: primary health care

Conditions of medical care: outpatient

Form of medical care: planned

Average treatment time (number of days): 14

1. Medical measures for diagnosing a disease, condition

The probability of providing medical services or prescribing drugs for medical use (medical devices) included in the standard of care, which can take values from 0 to 1, where 1 means that this event is carried out by 100% of patients corresponding to this model, and the numbers are less than 1 percentage of patients specified in the standard of care with relevant medical indications.

2. Medical services for the treatment of a disease, condition and treatment control

3

International Statistical Classification of Diseases and Related Health Problems, X revision.

International generic or chemical name of the medicinal product, and in their absence, the trade name of the medicinal product.

Average daily dose.

Average course dose.

1

2. 6724; 06/25/2012, N 26, art. 3442)).

3. 3699; 2004, N 35, Art. 3607; 2006, N 48, art. 4945; 2007, N 43, Art. 5084; 2008, N 9, Art. 817; 2008, N 29, Art. 3410; No. 52, art. 6224; 2009, N 18, art. 2152; No. 30, art. 3739; No. 52, art. 6417; 2010, No. 50, Art. 6603; 2011, N 27, art. 3880; 2012, N 31, st